Allworth Financial LP Has $36.70 Million Stock Position in UnitedHealth Group Incorporated $UNH

Allworth Financial LP cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 22.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 88,309 shares of the healthcare conglomerate’s stock after selling 25,105 shares during the period. Allworth Financial LP’s holdings in UnitedHealth Group were worth $36,704,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors acquired a new position in UnitedHealth Group in the 4th quarter valued at $25,000. Aberdeen Wealth Management LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $31,000. Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $27,000. Lifetime Wealth Management P.C. acquired a new stake in UnitedHealth Group in the 4th quarter worth about $29,000. Finally, Wilkerson Advisory Group LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on UNH. Weiss Ratings downgraded shares of UnitedHealth Group from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, July 28th. HSBC lifted their price objective on UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a report on Monday, July 6th. Barclays increased their target price on UnitedHealth Group from $429.00 to $441.00 and gave the stock an “overweight” rating in a report on Monday, July 20th. TD Cowen upped their price objective on shares of UnitedHealth Group from $337.00 to $430.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Finally, HC Wainwright set a $492.00 target price on shares of UnitedHealth Group in a report on Wednesday, May 27th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $456.56.

UnitedHealth Group Price Performance

Shares of UNH traded up $4.12 during midday trading on Tuesday, hitting $401.25. The company’s stock had a trading volume of 7,048,300 shares, compared to its average volume of 7,640,271. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The stock has a market capitalization of $360.16 billion, a price-to-earnings ratio of 25.82, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. The company’s fifty day simple moving average is $411.20 and its two-hundred day simple moving average is $365.42.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.